Alexis E Te1, Ahra Cho2, Bilal I Chughtai2. 1. Department of Urology, Weill Cornell Medical College of Cornell University, 425 East 61st street, 12th floor, New York, NY, 10065, USA. aet2005@med.cornell.edu. 2. Department of Urology, Weill Cornell Medical College of Cornell University, 425 East 61st street, 12th floor, New York, NY, 10065, USA.
Abstract
PURPOSE OF REVIEW: The goal of this paper is to review retreatment management after failed minimally invasive treatment (MIST) of various technologies. RECENT FINDINGS: A failed MIST can be defined by the return, persistence, or worsening of LUTS, as documented by symptom scores. Persistence, development, or recurrence of comorbidities such as recurrent urinary tract infection (UTI), retention, stones, hematuria, and incontinence can also signal a failed MIST. The common etiology for MIST failure is the preoperative consequence of long-term bladder outlet obstruction (BOO) on the bladder function. Close monitoring of therapies with antimuscarinics or beta-agonists can be empirically utilized if post-void bladder residual (PVR) is low. If there is a high PVR, urodynamic studies and cystoscopy can be used to determine overactive bladder (OAB), BOO, or necrosis. Depending on the timing of the observed BOO/OAB, subsequent retreatments involving transurethral debridement, medical and behavioral therapies, or repeat surgical debulking can be employed.
PURPOSE OF REVIEW: The goal of this paper is to review retreatment management after failed minimally invasive treatment (MIST) of various technologies. RECENT FINDINGS: A failed MIST can be defined by the return, persistence, or worsening of LUTS, as documented by symptom scores. Persistence, development, or recurrence of comorbidities such as recurrent urinary tract infection (UTI), retention, stones, hematuria, and incontinence can also signal a failed MIST. The common etiology for MIST failure is the preoperative consequence of long-term bladder outlet obstruction (BOO) on the bladder function. Close monitoring of therapies with antimuscarinics or beta-agonists can be empirically utilized if post-void bladder residual (PVR) is low. If there is a high PVR, urodynamic studies and cystoscopy can be used to determine overactive bladder (OAB), BOO, or necrosis. Depending on the timing of the observed BOO/OAB, subsequent retreatments involving transurethral debridement, medical and behavioral therapies, or repeat surgical debulking can be employed.
Authors: D L Floratos; G S Sonke; E A Francisca; L A Kiemeney; B B Kortmann; F M Debruyne; J J de la Rosette Journal: J Urol Date: 2000-05 Impact factor: 7.450
Authors: Jong Hyun Pyun; Sung Gu Kang; Seok Ho Kang; Jun Cheon; Je Jong Kim; Jeong Gu Lee Journal: Kaohsiung J Med Sci Date: 2017-07-13 Impact factor: 2.744
Authors: Oliver Reich; Christian Gratzke; Alexander Bachmann; Michael Seitz; Boris Schlenker; Peter Hermanek; Nicholas Lack; Christian G Stief Journal: J Urol Date: 2008-05-21 Impact factor: 7.450
Authors: Valentin Zumstein; Patrick Betschart; Malte W Vetterlein; Luis A Kluth; Lukas Hechelhammer; Livio Mordasini; Daniel S Engeler; Thomas M Kessler; Hans-Peter Schmid; Dominik Abt Journal: Eur Urol Focus Date: 2018-10-03